Body composition of HIV/AIDS males: Effects of treatment with insulin- like growth factor (IGF-I) and growth hormone (GH)

K. J. Ellis, P. D.K. Lee, J. M. Pivarnik, J. G. Bukar, N. Gesundheit

Research output: Contribution to journalArticle

5 Scopus citations

Abstract

A study was conducted to determine whether a pharmacological dose of insulin-like growth factor (IGF-I), administered with a low dose of growth hormone (GH), could produce an anabolic response in HIV/AIDS patients. The minimum effective GH dose needed, however, is not known. The GH dose selected was about an order of magnitude lower than that usually used for pharmacological treatment of GH deficiency. It was found that the moderate IGF-I dose combined with a low GH dose was insufficient to produce a detectable anabolic response as judged by the measurements of total body potassium (TBK) and total body nitrogen (TBN).

Original languageEnglish (US)
Pages (from-to)653-655
Number of pages3
JournalApplied Radiation and Isotopes
Volume49
Issue number5-6
DOIs
StatePublished - May 1 1998
Externally publishedYes

ASJC Scopus subject areas

  • Radiation

Fingerprint Dive into the research topics of 'Body composition of HIV/AIDS males: Effects of treatment with insulin- like growth factor (IGF-I) and growth hormone (GH)'. Together they form a unique fingerprint.

  • Cite this